Quick Facts

FONT-SIZE

Plus

Neg

SHARE

mail

E-MAIL

GW Pharma Slips To Loss In Six-month Period - Quick Facts

RELATED NEWS

GW Pharmaceuticals Closes IPO Of 3.50 Mln ADSs - Quick Facts

5/22/2012 2:58 AM ET

GW Pharmaceuticals Plc (GWP.L) posted six-month loss on ordinary activities after taxation of 3.17 million pounds or 2.4 pence per share versus loss of 3.29 million pounds or 2.4 pence per share last year.

Loss on ordinary activities before taxation was 4.1 million pounds compared to profit of 3.07 million pounds a year ago.

Six-month revenues declined year-over-year to 11.08 million pounds from 16.58 million pounds.

Click here to receive FREE breaking news email alerts for GW Pharmaceuticals PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Quick Facts

40 Articles Next>>

Editors Pick

Upbeat Economic Data Contributes To Rally On Wall Street - U.S. Commentary

Stocks moved sharply higher over the course of the trading day on Friday, more than offsetting the weakness seen on Thursday. In a reversal from the previous session, the markets benefited from some upbeat U.S. economic data as well as comments from a Federal Reserve official. The major averages saw further upside going into the close, with the Dow and the S&P 500 reaching new record highs.

PETA: IRS Targeting Neither New Nor Limited To Conservative Causes

As the IRS targeting scandal continues to make headlines, animal-protection charity People for the Ethical Treatment of Animals, or PETA, claims that conservative groups are not the only ones that have faced increased scrutiny from the agency.

Polls Shows Below Average Interest In IRS, Benghazi Stories

While the IRS targeting scandal has taken center stage on Capitol Hill on Friday, the results of a new Gallup poll showed that the American public's interest in the story is comparatively low based on historical measures. The poll showed that 54 percent of Americans are following the news that the IRS targeted conservative groups for greater scrutiny "very" or "somewhat" closely.

FREE Newsletters & Alerts

Breaking News Alerts

Daily Market Briefing

Health

Technology

Biotechnology

signup

Follow RTT

Most Read
Most E-Mailed

Genentech's Receives U.S FDA Approval For Tarceva Tablets, EGFR Mutation Test

Cable & Wireless Enters Into Strategic Alliance With Columbus Networks

Edwards Lifesciences CFO Abate To Retire; To Buy Back Up To Addl $750 Mln Shares

Reports: Google Priming To Launch Subscription-based Streaming Music Service

Ares Commercial Real Estate To Buy Alliant Capital LLC; Names Schuster Co-CEO

After-market Movers For May 15 (CSCO, TSLA, DDS, LMCA)

Pre-market Movers For May 16 (WMT, AAPL, GOOG, KSS, CSCO, TSLA, EGLE)

Lonrho, FS Africa Boards Agree On Terms Of Cash Offer - Quick Facts

Meredith Buys Parenting And Babytalk Brands From Bonnier

Apollo Investment Plans To Make Public Offering Of 18.0 Mln Shares

Cable & Wireless Enters Into Strategic Alliance With Columbus Networks

Genentech's Receives U.S FDA Approval For Tarceva Tablets, EGFR Mutation Test

Edwards Lifesciences CFO To Retire; Board Approves New $750 Mln Share Buyback

Ares Commercial Real Estate To Buy Alliant Capital LLC; Names Schuster Co-CEO

Hydro International Names Michael Jennings CEO

Kindred, Dignity Health To Create JV

WSJ: SEC Considers Charles Schwab Executive To Head Trading And Markets Division

Allianz Q1 Profit Climbs 24%; Backs Full-year Profit Outlook

Compass Group Six-month Profit Down; Maintains Positive FY Outlook - Quick Facts

RHJ Int'l To Sell 39% Stake In Shaklee Global Via Share Buyback Transaction

FREE Newsletters, Analysis & Alerts

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.

Email Address